Analysis Metabolite Name Measured Value Units CASE_CONTROL Chemotherapy Drug Race TIMEPOINT Tamoxyfen Taxane
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+1346Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+1849Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+1869Peak areaControl N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+1983Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+3026Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+3327Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+4389Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+5093Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+5120Peak areaControl N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+5465Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+5924Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+6358Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+7223Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+7673Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+7974Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+8214Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+8509Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+8844Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+9853Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+10084Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+11122Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+12518Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+12664Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+12852Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+13534Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+14535Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+15756Peak areaCase N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+15905Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+17538Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+17747Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+17748Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+18446Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+18534Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+18907Peak areaCase N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+19068Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+19237Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+19561Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+20042Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+21048Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+21325Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+21521Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+22991Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+23169Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+24966Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+25906Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+26296Peak areaControl Y Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+26721Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+27427Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+27547Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+30230Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+30237Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+31407Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+31467Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+31468Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+31499Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+31662Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+31947Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+31999Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+32081Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+35395Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+35846Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+36359Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+36685Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+41989Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+44200Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+45003Peak areaControl N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+46826Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+47375Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+49014Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+49330Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+49503Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+49629Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+50864Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+51224Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+51679Peak areaControl N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+53276Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+54112Peak areaCase N Exemestane Black 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+54795Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+60422Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+61825Peak areaControl N Exemestane Black Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+65827Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+72365Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+95874Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+100627Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+104135Peak areaCase N Exemestane Black Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+130853Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+234808Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+489828Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+494333Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+531929Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+573038Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+H)+Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+5335Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+6038Peak areaCase N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+8403Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+8956Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+9219Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+9443Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+9519Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+11639Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+12815Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+13624Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+13763Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+16907Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+17052Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+17202Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+21544Peak areaCase N Exemestane Black Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+23318Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+32275Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+33024Peak areaCase N Exemestane Black 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+38995Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+57781Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+62893Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+73304Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+81666Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Exemestane Black Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODESEROTONIN (CAS# 50-67-9); (M+NA)+Peak areaControl Y Letrozole White Baseline Y Y

Return to search page
  logo